Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 13 studies | 35% ± 17% | |
non-classical monocyte | 12 studies | 28% ± 12% | |
CD8-positive, alpha-beta T cell | 7 studies | 25% ± 8% | |
natural killer cell | 6 studies | 21% ± 2% | |
CD4-positive, alpha-beta T cell | 5 studies | 27% ± 9% | |
pro-B cell | 5 studies | 48% ± 10% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 18% ± 1% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 22% ± 3% | |
B cell | 3 studies | 29% ± 5% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 26% ± 8% | |
T cell | 3 studies | 25% ± 8% |
Insufficient scRNA-seq data for expression of ADA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 2531.09 | 359 / 359 | 98% | 15.29 | 279 / 286 |
skin | 100% | 809.74 | 1803 / 1809 | 98% | 17.36 | 462 / 472 |
esophagus | 100% | 789.81 | 1445 / 1445 | 97% | 18.01 | 178 / 183 |
breast | 100% | 1074.64 | 458 / 459 | 96% | 10.46 | 1073 / 1118 |
uterus | 99% | 485.01 | 168 / 170 | 96% | 22.91 | 442 / 459 |
lung | 100% | 755.96 | 576 / 578 | 95% | 18.41 | 1092 / 1155 |
intestine | 99% | 612.88 | 954 / 966 | 95% | 15.03 | 499 / 527 |
thymus | 100% | 658.09 | 650 / 653 | 90% | 67.11 | 542 / 605 |
bladder | 95% | 548.86 | 20 / 21 | 89% | 17.79 | 448 / 504 |
pancreas | 84% | 226.19 | 275 / 328 | 94% | 13.46 | 168 / 178 |
kidney | 84% | 285.85 | 75 / 89 | 85% | 10.21 | 768 / 901 |
ovary | 70% | 210.34 | 126 / 180 | 98% | 11.33 | 420 / 430 |
brain | 68% | 249.81 | 1805 / 2642 | 92% | 9.82 | 646 / 705 |
adrenal gland | 100% | 529.69 | 258 / 258 | 52% | 4.21 | 119 / 230 |
liver | 62% | 169.85 | 140 / 226 | 82% | 6.74 | 332 / 406 |
prostate | 96% | 500.27 | 236 / 245 | 30% | 1.43 | 151 / 502 |
adipose | 100% | 1489.38 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 179.12 | 29 / 29 |
spleen | 100% | 1504.94 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.22 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.35 | 1 / 1 |
heart | 100% | 1005.07 | 860 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 8.63 | 77 / 80 |
muscle | 94% | 312.20 | 756 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 1793.83 | 861 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 85% | 427.80 | 1131 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002906 | Biological process | negative regulation of mature B cell apoptotic process |
GO_0006939 | Biological process | smooth muscle contraction |
GO_0050862 | Biological process | positive regulation of T cell receptor signaling pathway |
GO_0044209 | Biological process | AMP salvage |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0002686 | Biological process | negative regulation of leukocyte migration |
GO_0050850 | Biological process | positive regulation of calcium-mediated signaling |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0046103 | Biological process | inosine biosynthetic process |
GO_0002467 | Biological process | germinal center formation |
GO_0006196 | Biological process | AMP catabolic process |
GO_0006157 | Biological process | deoxyadenosine catabolic process |
GO_0070256 | Biological process | negative regulation of mucus secretion |
GO_0001829 | Biological process | trophectodermal cell differentiation |
GO_0000255 | Biological process | allantoin metabolic process |
GO_0048566 | Biological process | embryonic digestive tract development |
GO_0014074 | Biological process | response to purine-containing compound |
GO_0001889 | Biological process | liver development |
GO_0007155 | Biological process | cell adhesion |
GO_0046085 | Biological process | adenosine metabolic process |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0032261 | Biological process | purine nucleotide salvage |
GO_0043103 | Biological process | hypoxanthine salvage |
GO_0048541 | Biological process | Peyer's patch development |
GO_0070242 | Biological process | thymocyte apoptotic process |
GO_0001890 | Biological process | placenta development |
GO_0060169 | Biological process | negative regulation of adenosine receptor signaling pathway |
GO_0032263 | Biological process | GMP salvage |
GO_0033632 | Biological process | regulation of cell-cell adhesion mediated by integrin |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_0043084 | Biological process | penile erection |
GO_0046059 | Biological process | dAMP catabolic process |
GO_0002314 | Biological process | germinal center B cell differentiation |
GO_0043605 | Biological process | amide catabolic process |
GO_0045987 | Biological process | positive regulation of smooth muscle contraction |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0002901 | Biological process | mature B cell apoptotic process |
GO_0050900 | Biological process | leukocyte migration |
GO_0001666 | Biological process | response to hypoxia |
GO_0043101 | Biological process | purine-containing compound salvage |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0046111 | Biological process | xanthine biosynthetic process |
GO_0006154 | Biological process | adenosine catabolic process |
GO_0060407 | Biological process | negative regulation of penile erection |
GO_0070244 | Biological process | negative regulation of thymocyte apoptotic process |
GO_0033089 | Biological process | positive regulation of T cell differentiation in thymus |
GO_0042100 | Biological process | B cell proliferation |
GO_0070254 | Biological process | mucus secretion |
GO_0046632 | Biological process | alpha-beta T cell differentiation |
GO_0046638 | Biological process | positive regulation of alpha-beta T cell differentiation |
GO_0002636 | Biological process | positive regulation of germinal center formation |
GO_0042110 | Biological process | T cell activation |
GO_0010460 | Biological process | positive regulation of heart rate |
GO_0048286 | Biological process | lung alveolus development |
GO_0046061 | Biological process | dATP catabolic process |
GO_0060205 | Cellular component | cytoplasmic vesicle lumen |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005764 | Cellular component | lysosome |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0070161 | Cellular component | anchoring junction |
GO_0019239 | Molecular function | deaminase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0046936 | Molecular function | 2'-deoxyadenosine deaminase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004000 | Molecular function | adenosine deaminase activity |
Gene name | ADA |
Protein name | Adenosine deaminase Mutant adenosine deaminase adenosine deaminase (EC 3.5.4.4) Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase) Adenosine deaminase (EC 3.5.4.4) |
Synonyms | hCG_38105 ADA1 |
Description | FUNCTION: Catalyzes the hydrolytic deamination of adenosine and 2-deoxyadenosine . Plays an important role in purine metabolism and in adenosine homeostasis. Modulates signaling by extracellular adenosine, and so contributes indirectly to cellular signaling events. Acts as a positive regulator of T-cell coactivation, by binding DPP4 . Its interaction with DPP4 regulates lymphocyte-epithelial cell adhesion . Enhances dendritic cell immunogenicity by affecting dendritic cell costimulatory molecule expression and cytokines and chemokines secretion (By similarity). Enhances CD4+ T-cell differentiation and proliferation . Acts as a positive modulator of adenosine receptors ADORA1 and ADORA2A, by enhancing their ligand affinity via conformational change . Stimulates plasminogen activation . Plays a role in male fertility . Plays a protective role in early postimplantation embryonic development (By similarity). . |
Accessions | ENST00000537820.2 ENST00000695949.1 ENST00000696082.1 ENST00000695956.1 A0A0S2Z3T6 A0A8Q3SIC0 A0A8Q3SIG8 F5GXW0 ENST00000695891.1 X5D767 ENST00000696006.1 A0A8Q3WKY2 A0A8Q3WL01 A0A8Q3WKZ1 ENST00000695957.1 ENST00000695992.1 ENST00000696080.1 ENST00000695994.1 A0A8Q3WKW4 A0A8Q3SIC7 A0A8Q3SIA9 ENST00000696078.1 ENST00000696105.1 A0A8Q3WKZ4 A0A8Q3SI46 ENST00000695927.1 A0A8Q3WLJ0 A0A8Q3WM09 ENST00000696065.1 ENST00000696038.1 ENST00000696017.1 ENST00000696077.1 ENST00000695889.1 A0A8Q3SIE4 ENST00000539235.6 A0A8Q3SIH0 F5GYD4 ENST00000696034.1 ENST00000696058.1 A0A8Q3SJ63 ENST00000695991.1 ENST00000372874.9 P00813 A0A8Q3SJ25 ENST00000695995.1 A0A8Q3WM84 A0A8Q3WL06 A0A8Q3SI64 A0A8Q3SI69 A0A8Q3WKX8 Q16073 ENST00000696079.1 ENST00000696076.1 ENST00000696061.1 ENST00000696104.1 ENST00000696064.1 ENST00000696007.1 F5GWI4 A0A8Q3WL32 A0A0S2Z3B9 A0A8Q3SJ57 ENST00000696075.1 ENST00000696060.1 ENST00000536532.6 ENST00000536076.2 ENST00000696059.1 A0A8Q3WKZ6 A0A0S2Z381 A0A8Q3WKX5 ENST00000696063.1 ENST00000696062.1 A0A8Q3WKZ9 A0A8Q3SJ50 ENST00000695993.1 ENST00000696005.1 A0A8Q3WKZ5 A0A8Q3WM58 A0A8Q3WLK2 |